Robert A Harrison Selected Research

Snake Venoms (Snake Venom)

6/2022	Correction: Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
6/2022	In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.
1/2022	Profiling the Murine Acute Phase and Inflammatory Responses to African Snake Venom: An Approach to Inform Acute Snakebite Pathology.
1/2021	Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
12/2020	In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms.
1/2019	A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite.
11/2018	Analgesic effect of morphine and tramadol in standard toxicity assays in mice injected with venom of the snake Bothrops asper.
1/2018	The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms.
1/2017	Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.
1/2016	Stabilising the Integrity of Snake Venom mRNA Stored under Tropical Field Conditions Expands Research Horizons.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Harrison Research Topics

Disease

34	Snake Bites (Snake Bite) 06/2022 - 11/2009
3	Disseminated Intravascular Coagulation 06/2022 - 04/2017
3	Neglected Diseases 01/2015 - 08/2011
3	Hemorrhage 09/2013 - 06/2006
2	Pain (Aches) 01/2021 - 11/2018
2	Necrosis 09/2013 - 03/2011
1	Hemolysis 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Bites and Stings (Sting) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Paralysis (Palsy) 01/2019
1	Edema (Dropsy) 11/2018
1	Adenocarcinoma of Lung 09/2013
1	Neoplasms (Cancer) 09/2013
1	Thrombosis (Thrombus) 07/2012
1	Hypotension (Low Blood Pressure) 03/2010
1	Myocardial Infarction 03/2010
1	Blood Coagulation Disorders 03/2010
1	Stroke (Strokes) 03/2010
1	Serum Sickness 06/2006
1	Infections 04/2004

Drug/Important Bio-Agent (IBA)

30	Antivenins (Antivenoms)IBA 06/2022 - 06/2006
16	VenomsIBA 06/2022 - 11/2009
14	Snake Venoms (Snake Venom)IBA 06/2022 - 06/2006
3	EnzymesIBA 01/2018 - 03/2010
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2010
3	Immunoglobulin G (IgG)IBA 09/2010 - 04/2004
2	Unithiol (DMPS)IBA 06/2022 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 06/2022 - 06/2006
2	Fibrinogen (Factor I)FDA Link 06/2022 - 07/2012
2	AntibodiesIBA 12/2020 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Serine Proteases (Serine Protease)IBA 01/2011 - 03/2010
1	marimastatIBA 06/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2022
1	Prothrombin (Factor II)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	SuspensionsIBA 01/2021
1	MetalsIBA 01/2020
1	Chelating AgentsIBA 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019
1	Three Finger ToxinsIBA 01/2019
1	NeurotoxinsIBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 11/2018
1	Tramadol (K315)FDA LinkGeneric 11/2018
1	Analgesics (Analgesic Drugs)IBA 11/2018
1	IntegrinsIBA 07/2012
1	CollagenIBA 07/2012
1	CalciumIBA 07/2012
1	SolutionsIBA 08/2011
1	Cytotoxins (Cytolysins)IBA 03/2011
1	Immunoglobulins (Immunoglobulin)IBA 06/2006
1	AntigensIBA 06/2006
1	DNA (Deoxyribonucleic Acid)IBA 06/2006
1	EpitopesIBA 06/2006

Therapy/Procedure

13	Therapeutics 06/2022 - 11/2009
1	First Aid (Aids, First) 01/2022
1	Pain Management 01/2021
1	Intravenous Administration 12/2020
1	Complementary Therapies (Alternative Medicine) 01/2018
1	Mass Drug Administration 01/2015